Polyclonal immunoglobulin for treatment of bacterial sepsis: A systematic reviewPILDAL, Julie; GØTZSCHE, Peter C.Clinical infectious diseases. 2004, Vol 39, Num 1, pp 38-46, issn 1058-4838, 9 p.Article

Comparison of descriptions of allocation concealment in trial protocols and the published reports : cohort studyPILDAL, Julie; CHAN, An-Wen; HROBJARTSSON, Asbjørn et al.BMJ. British medical journal (International ed.). 2005, Vol 330, Num 7499, pp 1049-1052, issn 0959-8146, 4 p.Article

Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled TrialsSAVOVIC, Jelena; JONES, Hayley E; LOANNIDIS, John P. A et al.Annals of internal medicine. 2012, Vol 157, Num 6, pp 429-438, issn 0003-4819, 10 p.Article

Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictoryHROBJARTSSON, Asbjørn; PILDAL, Julie; CHAN, An-Wen et al.Journal of clinical epidemiology. 2009, Vol 62, Num 9, pp 967-973, issn 0895-4356, 7 p.Article

Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitusMØLLER, Ann M; JENSEN, Niels M; PILDAL, Julie et al.The Journal of clinical endocrinology and metabolism. 2001, Vol 86, Num 5, pp 2181-2186, issn 0021-972XArticle